Kim WR. Survival Benefits of Direct-Acting Antiviral Therapy in Patients with Decompensated Hepatitis C Cirrhosis. PS-151.
Resistentie-analyse HCV na ledipasvir/sofosbuvir
sep 2017 | Hepatitis
jun 2024 | Niertransplantatie, Stamceltransplantatie, Virale infecties